Ion Beam Applications SA (IOBCF)
- Globe Newswire
IBA - Regulated Information
IBA SA – Regulated information January 25th, 2023 Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market and containing various provisions (Belgian Gazette 12.VI.2007 ) (hereinafter, the “Law”) Under this provision: "[...] the issuer publishes the total capital, the total number of securities conferring the right to vote and voting rights, as well as, by category, the number of
- Globe Newswire
IBA announces contract with Moffitt Cancer Center for a Proteus®ONE proton therapy solution in Florida, US
Louvain-La-Neuve, Belgium, 10 January 2023 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces that it has received the downpayment for a contract signed at the end of December 2022 with the H. Lee Moffitt Cancer Center and Research Institute Hospital (“Moffitt”) in Tampa, Florida, US, for the installation of its Proteus®ONE1 compact proton therapy system. As Florida’s only National Cancer Institute-designated comprehensive cancer ce
- Globe Newswire
IBA Wins 10 Proton Therapy System Contract in Spain
Louvain-La-Neuve, Belgium, 08 December 2022 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today confirms that it has signed a contract with the Spanish Ministry of Health to install ten proton therapy systems across Spain as part of a significant public tender. This follows the announcement in August that IBA had qualified as the only supplier of the tender. The total value of the contract to IBA is currently EUR 217 million, all taxes exclude
